$10 Billion Deal, page-8907

First 8907 Last

Share
Profile

Follow
luxury

3,612 Posts.

331

16/12/21

09:09

Post #: 58326661
Share

Originally posted by malmanu: ↑

Drug resistance will determine the use of a cocktail of antivirals targeting the same target .

The Pfizer drug Paxlovid is made up of two protease inhibitors so already advantageous to overcome resistance if it eventuates. There is currently only one mutation in the 3CL protease , an enzyme targeted by Pfizers antiviral pill Paxlovid the most advanced of the main protease Mpro target . Other Mpro targeting compounds are also in development and will be useful as combination drugs if multiple mutations develop.

BIT is going it alone targeting the E protein so far.

https://www.nature.com/articles/d41573-021-00202-8
During viral replication, SARS-CoV-2 synthesizes long polypeptides that must be cleaved into its constituent viral proteins. Mpro carries out most of this cleavage. Inhibiting Mpro thus prevents the virus from generating the proteins it needs to replicate.
“Mpro is a great target because it’s kind of the Achilles heel of the virus,” says Rolf Hilgenfeld, an antiviral researcher from the University of Lübeck, Germany.

https://www.medicalnewstoday.com/articles/pfizer-oral-antiviral-safe-and-effective-against-sars-cov-2
Dr. Adam Bailey, an assistant professor in the Department of Pathology and Laboratory Medicine at the University of Wisconsin–Madison, explained the rationale behind this duo of drugs toMedical News Today.

"These are both protease inhibitors. Drug cocktails that have the same target can often be a successful way to reduce the likelihood of drug [resistant] mutations cropping up. Instead of striking upon a single mutation that confers resistance to one drug, the virus must acquire two or more different mutations to generate resistance to both drugs simultaneously"

Expand

The sad thing is the "cheap as chips" Ivermectin is just as strong a protease inhibitor but is manipulated out of the picture by big pharma.

Join the March for Ivermectin.
(further info can be obtained from either myself or Beno 77).

BIT Price at posting: 7.9¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint